- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02059980
Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania
August 28, 2018 updated by: Han Joo Lee, University of Wisconsin, Milwaukee
Developing Effective Response Inhibition Training for Symptom Relief in Obsessive-Compulsive and Related Disorders and Trichotillomania
Obsessive-compulsive disorder (OCD) and its related disorders (e.g., trichotillomania) are characterized by the marked difficulty in inhibiting unwanted or inappropriate responses.
There is compelling evidence that poor response inhibition is a core cognitive feature of OCD and its related disorders, but no effective intervention exists that directly attempts to address this problematic cognitive deficiency.
This study will examine the feasibility and clinical utility of a computerized cognitive training program designed to improve response inhibition among individuals diagnosed with OCD or trichotillomania.This training program offers systematic practice of response inhibition in the form of a 40-level computer game.
Individuals with these conditions will be randomized to either 8 sessions of (a) computerized response inhibition training (RIT) or (b) placebo computer training (PLT).
We hypothesize that RIT will outperform PLT in improving response inhibition capabilities and reducing relevant clinical symptoms.
In sum, this project is expected to generate important knowledge to guide the development of effective computer-based treatment approaches that may help reduce critical problems of existing treatments such as suboptimal patient retention and treatment under-utilization, thereby improving overall treatment response rates among individuals suffering from OCD and related conditions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53211
- Psychology Clinic, University of Wisconsin-Milwaukee
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Principal diagnosis of obsessive-compulsive disorder or trichotillomania
Exclusion Criteria:
- Current substance use problems
- Current/Past Psychotic disorder, bipolar disorder, or schizophrenia
- Attention deficit/hyperactivity disorder or tic disorder
- Severe depressive symptoms
- Current psychotherapy
- Current suicidality
- Estimated intellectual functioning < 80
- Lack of response inhibition deficits on a stop-signal task
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Response inhibition training
Eight 45-minute sessions of computerized training on response inhibition over a 4 week period
|
This is a computerized video game that offers 40 training levels, which aims to enhance the individual's response inhibition performance
|
|
Placebo Comparator: Placebo Control Training
Eight 45-minute sessions of computerized placebo control training over a 4 week period
|
This placebo control training looks very similar to the response inhibition training program in its appearance.
However, it does not offer any practice related to response inhibition capabilities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite Score of Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and National Institute of Mental Health (NIMH)
Time Frame: Baseline, Week 4, and Week 8
|
This is a clinician-administered rating scale of OCD symptom severity, most widely used in treatment outcome research for OCD, and a clinician-administered rating scale of hair pulling symptoms, widely used in clinical trial research for trichotillomania.
Given the inclusion of two different diagnostic conditions, the primary outcome for the current study is the z score of the symptom rating severity obtained from the two rating scales, with higher values indicating greater symptom severity.
|
Baseline, Week 4, and Week 8
|
|
Stop Signal Reaction Time
Time Frame: Baseline, Week 4, and Week 8
|
Stop Signal Reaction Time (SSRT; time taken to complete the inhibitory process) is estimated using the tracking algorithm on the computerized stop-signal task, which adjusts the stop signal delay automatically (by 50ms) to maintain the rate of successful inhibition on stop-signal trials at 50%.
|
Baseline, Week 4, and Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression Severity and Improvement
Time Frame: Baseline, Week 4, and Week 8
|
The Clinical Global Impression Severity and Improvement (CGI) is a clinician-administered rating scale widely used to assess the overall severity of the target condition in treatment outcome research.
The CGI is assessed on a 7-point scale, with the severity scale from 1 (Normal, not at all ill) through to 7 (Among the most severely ill patients).
Thus, the higher CGI severity rating score indicate a greater level of overall illness.
|
Baseline, Week 4, and Week 8
|
|
Commission Errors on the Go/No-go Task.
Time Frame: Baseline, Week 4, and Week 8
|
The number of commission errors on the go/no-go task is a commonly used measure of response inhibition.
In this task, participants are asked to withhold their responses on no-go trials.
If they fail to withhold their response in a no-go trial (i.e., pressing the response key to the no-go signal), this response counts toward the total number of commission errors.
Therefore, a greater number of commission errors on this task reflects a greater level of inhibitory control deficit.
|
Baseline, Week 4, and Week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
February 7, 2014
First Submitted That Met QC Criteria
February 7, 2014
First Posted (Estimate)
February 11, 2014
Study Record Updates
Last Update Posted (Actual)
September 26, 2018
Last Update Submitted That Met QC Criteria
August 28, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21-RIT_OC-LEE
- R21MH094537 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive Compulsive Disorder
-
Shanghai Pudong New Area Mental Health Center,...RecruitingObsessive Compulsive Disorder (OCD) | Obsessive - Compulsive DisorderChina
-
National Institute of Mental Health, Czech RepublicRecruitingObsessive-compulsive DisorderCzechia
-
Assiut UniversityNot yet recruitingSubstance Use | Substance Abuse Disorder | Obsessive Compulsive Disorder (OCD) | Obsessive Compulsive Behavior | Obsessive - Compulsive Disorder
-
ASST Fatebenefratelli SaccoFondazione IRCCS San Gerardo dei Tintori; Istittuo ricerca carattere Sceintifico...Enrolling by invitationObsessive - Compulsive DisorderItaly
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Shanghai Mental Health CenterNot yet recruitingObsessive - Compulsive DisorderChina
-
Adam FrankRecruitingObsessive - Compulsive DisorderUnited States
-
Taipei Veterans General Hospital, TaiwanRecruitingObsessive-Compulsive Disorder (OCD)Taiwan
-
VU University of AmsterdamUniversity of Bern; Stockholm University; Thomas More University of Applied SciencesNot yet recruitingObsessive Compulsive Disorder (OCD)Sweden, Belgium, Netherlands, Switzerland
-
Butler HospitalNot yet recruitingPostpartum Obsessive Compulsive Disorder
Clinical Trials on Response inhibition training
-
University of Wisconsin, MilwaukeeCompletedWilliams SyndromeUnited States
-
Babes-Bolyai UniversityCompleted
-
University of Wisconsin, MilwaukeeTrichotillomania Learning CenterCompleted
-
North Dakota State UniversityUnknown
-
Karolinska InstitutetCompleted
-
University of Wisconsin, MilwaukeeTourette Association of AmericaCompletedTourette Syndrome | Chronic Tic DisordersUnited States
-
William Beaumont Army Medical CenterTerminatedPosttraumatic Stress DisorderUnited States
-
Yale UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAutism Spectrum DisordersUnited States
-
US Department of Veterans AffairsCompletedLanguage Disorders | Aphasia | Speech DisordersUnited States
-
Oregon Research InstituteUniversity of Oregon; Radboud University Medical Center; University of Exeter; Flinders...CompletedObesity | Feeding and Eating Disorders | HyperphagiaUnited States